Ballantyne Therapeutics
Charlotte, US · Founded 2014 · Delaware corporation
Founders & leadership
MR
Michael RobertsExecutive
Board
BE
Brian E. DoxtatorBoard director
DR
Donald R ReynoldsBoard director
SP
Simon PedderBoard director
Reported raises · per SEC filings
Form D private placements$565K disclosed across 1 round · 2015
▶$565KraisedOct 2015 · 8 investors · PharmaceuticalsRule 506(b)
▶$565KraisedOct 2015 · 8 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Brian E. DoxtatorDirector
- Michael RobertsExecutive Officer, Director
- Donald R ReynoldsDirector
- Simon PedderDirector
- Offering amount
- $800K
- Amount sold
- $565K
- First sale
- May 2015
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Ballantyne Therapeutics raised?
- Ballantyne Therapeutics has disclosed $565K raised across 1 round.
- Where is Ballantyne Therapeutics headquartered?
- Ballantyne Therapeutics is headquartered in Charlotte, US.